1. In two days, Minneapolis-based Medtronic announced two acquisition deals. In the first deal, Medtronic acquired Sapiens Steering Brain Stimulation, a Dutch company developing brain stimulation technologies, for approximately $200 million in cash.
2. Medtronic’s second acquisition was of Italian company NGC Medical S.p.A for $350 million. NGC manages cardiovascular suites, operating rooms and intensive care units for hospitals.
3. Dublin, Ireland-based Covidien acquired Irvine, Calif.-based Reverse Medical Corp. Reverse Medical is a medical device company focused on vascular disease management.
4. Roche, a Swiss pharmaceutical company, plans to acquire Brisbane, Calif.-based InterMune, a biotech firm, for $8.3 billion.
5. St. Paul, Minn.-based St. Jude Medical signed a definitive agreement to acquire NeuroTherm, a chronic pain solutions device company.
More articles on device manufacturers:
Another push to repeal Medical Device Tax follows low IRS revenue report
15 things to know about the Medical Device Tax
The ins and outs of third party reprocessing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
